[26P2-pm1] Clinical Pharmacy 1/Social pharmacy 1

[26P2-pm1-064S] Association of afatinib pharmacokinetics and genetic polymorphisms with adverse events in patients with non-small cell lung cancer.

○Chishima Haruna¹, Yuta Yokoyama^1,2, Emi Ishikawa², Motonori Kimura³, Jun Hakamata³, Hideo Nakada³, Naoya Suehiro³, Shinnosuke Ikemura⁴, Ichiro Kawada⁵, Hiroyuki Yasuda⁵, Hideki Terai⁵, Aya Jibiki¹, Hitoshi Kawazoe^1,2, Kenzo Soejima⁴, Hiroshi Muramatsu³, Sayo Suzuki^1,2, Tomonori Nakamura^1,2 (1. Faculty Pharm., Keio Univ., 2. Keio Univ. Grad. Sch. Pharm., 3. Keio Univ. Hosp. Dep. Pharm., 4. Grad. Sch. Med., Univ. Yamanashi, 5. Keio Univ. Sch. Med.)